Palatianos G M, Thurer R J, Pompeo M Q, Kaiser G A
Division of Thoracic and Cardiovascular Surgery, University of Miami School of Medicine, Florida 33101.
Ann Thorac Surg. 1989 Sep;48(3):381-5. doi: 10.1016/s0003-4975(10)62862-7.
To assess the effectiveness of subxiphoid pericardial tube drainage for treatment of pericardial effusion, we reviewed 41 consecutive patients who underwent this procedure during a 14-year period. The patients ranged in age from 7 months to 75 years. All were symptomatic preoperatively. The diagnosis of pericardial effusion was confirmed by echocardiogram in all but 2 patients. Eight patients had acute pericardial tamponade. Subxiphoid pericardial drainage was performed under general (n = 35) or local anesthesia (n = 6). A portion of the anterior pericardium was excised in each patient. There were no perioperative deaths. Thirty-day mortality was 19.5%; there were five late deaths. All deaths were unrelated to pericardial effusion or to the operation. One patient had recurrent effusion requiring pericardiocentesis on the 21st postoperative day. He died five days later of extensive lymphoma. Twenty-eight patients were followed from 1 month to 10 years; mean follow-up was 31.5 months. None developed recurrent effusion or pericardial constriction. We conclude that subxiphoid pericardial drainage is effective for treatment of pericardial effusion.
为评估剑突下心包置管引流治疗心包积液的有效性,我们回顾了14年间连续接受该手术的41例患者。患者年龄从7个月至75岁不等。所有患者术前均有症状。除2例患者外,其余患者均经超声心动图确诊心包积液。8例患者发生急性心包填塞。剑突下心包引流在全身麻醉(n = 35)或局部麻醉(n = 6)下进行。每位患者均切除部分心包前壁。围手术期无死亡病例。30天死亡率为19.5%;有5例晚期死亡。所有死亡均与心包积液或手术无关。1例患者术后第21天出现复发性积液,需行心包穿刺术。5天后因广泛淋巴瘤死亡。28例患者随访1个月至10年;平均随访时间为31.5个月。无一例发生复发性积液或心包缩窄。我们得出结论,剑突下心包引流治疗心包积液有效。